期刊
CANCER PREVENTION RESEARCH
卷 3, 期 4, 页码 403-405出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1940-6207.CAPR-10-0042
关键词
-
类别
资金
- NATIONAL CANCER INSTITUTE [R01CA140594, R01CA122794] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [R01AG027757] Funding Source: NIH RePORTER
- NCI NIH HHS [R01 CA140594-01, R01 CA122794-04, R01 CA140594, R01 CA122794] Funding Source: Medline
- NIA NIH HHS [R01 AG027757, R01 AG027757-04] Funding Source: Medline
This perspective on Deng et al. (beginning on p. 424 in this issue of the journal) examines the link between NF-kappa B and lung tumorigenesis. Experiments in genetically engineered mouse models of lung cancers are elucidating protumorigenic roles of NF-kappa B activation in lung cancer pathogenesis. Our growing understanding of the tumor-promoting NF-kappa B downstream effector pathways could lead to the development of novel approaches for lung cancer therapy and chemoprevention. Cancer Prev Res; 3(4); 403-5. (C)2010 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据